These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25343451)

  • 1. The dual role of scavenger receptor class A in development of diabetes in autoimmune NOD mice.
    Shimizu M; Yasuda H; Hara K; Takahashi K; Nagata M; Yokono K
    PLoS One; 2014; 9(10):e109531. PubMed ID: 25343451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
    Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
    J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro.
    Pileggi GS; Clemencio AD; Malardo T; Antonini SR; Bonato VL; Rios WM; Silva CL
    BMC Biotechnol; 2016 May; 16(1):40. PubMed ID: 27165305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
    Pane JA; Webster NL; Zufferey C; Coulson BS
    Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
    Serreze DV; Gaskins HR; Leiter EH
    J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
    Fukushima K; Abiru N; Nagayama Y; Kobayashi M; Satoh T; Nakahara M; Kawasaki E; Yamasaki H; Ueha S; Matsushima K; Liu E; Eguchi K
    Biochem Biophys Res Commun; 2008 Mar; 367(4):719-24. PubMed ID: 18194666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell vaccination against autoimmune diabetes in nonobese diabetic mice.
    Formby B; Shao T
    Ann Clin Lab Sci; 1993; 23(2):137-47. PubMed ID: 8096128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice.
    Mellanby RJ; Phillips JM; Parish NM; Cooke A
    Autoimmunity; 2008 Aug; 41(5):383-94. PubMed ID: 18568644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
    Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages.
    Nakahara M; Nagayama Y; Ichikawa T; Yu L; Eisenbarth GS; Abiru N
    Autoimmunity; 2011 Sep; 44(6):504-10. PubMed ID: 21306188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
    Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
    Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes.
    Thomas HE; Graham KL; Chee J; Thomas R; Kay TW; Krishnamurthy B
    Ann N Y Acad Sci; 2013 Apr; 1283():81-6. PubMed ID: 23167495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class II.
    Tsai S; Serra P; Clemente-Casares X; Slattery RM; Santamaria P
    J Immunol; 2013 Jul; 191(1):70-82. PubMed ID: 23740949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.